IL139708A0 - Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering - Google Patents

Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering

Info

Publication number
IL139708A0
IL139708A0 IL13970800A IL13970800A IL139708A0 IL 139708 A0 IL139708 A0 IL 139708A0 IL 13970800 A IL13970800 A IL 13970800A IL 13970800 A IL13970800 A IL 13970800A IL 139708 A0 IL139708 A0 IL 139708A0
Authority
IL
Israel
Prior art keywords
biological matrices
tissue engineering
decellularizing
acellular
useful
Prior art date
Application number
IL13970800A
Original Assignee
Amiel Gilad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amiel Gilad filed Critical Amiel Gilad
Priority to IL13970800A priority Critical patent/IL139708A0/en
Priority to PCT/IL2001/001060 priority patent/WO2002040630A2/en
Priority to AU2002224003A priority patent/AU2002224003A1/en
Publication of IL139708A0 publication Critical patent/IL139708A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
IL13970800A 2000-11-15 2000-11-15 Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering IL139708A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IL13970800A IL139708A0 (en) 2000-11-15 2000-11-15 Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering
PCT/IL2001/001060 WO2002040630A2 (en) 2000-11-15 2001-11-15 Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering
AU2002224003A AU2002224003A1 (en) 2000-11-15 2001-11-15 Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL13970800A IL139708A0 (en) 2000-11-15 2000-11-15 Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering

Publications (1)

Publication Number Publication Date
IL139708A0 true IL139708A0 (en) 2002-02-10

Family

ID=11074822

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13970800A IL139708A0 (en) 2000-11-15 2000-11-15 Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering

Country Status (3)

Country Link
AU (1) AU2002224003A1 (en)
IL (1) IL139708A0 (en)
WO (1) WO2002040630A2 (en)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4092397B2 (en) * 2002-09-10 2008-05-28 国立循環器病センター総長 Treatment of living tissue for transplantation by applying ultrahigh hydrostatic pressure
US7459154B2 (en) * 2002-12-26 2008-12-02 Cell Genesys, Inc. Methods and reagents for the enhancement of virus transduction in the bladder epithelium
AU2004270239C1 (en) 2003-09-04 2011-07-07 Cook Biotech Incorporated Extracellular matrix composite materials, and manufacture and use thereof
AU2005323327B2 (en) * 2005-01-05 2009-11-05 The Cleveland Clinic Foundation Method for fixing tissue
WO2006102063A2 (en) 2005-03-19 2006-09-28 Cook Biotech Incorporated Prosthetic implants including ecm composite material
EP1902127B1 (en) * 2005-04-15 2012-08-29 Wake Forest University Health Sciences Bioreactor system and method of enhancing functionality of muscle cultured in vitro
EP1719533A1 (en) * 2005-05-04 2006-11-08 Tecnobiomedica S.p.A. Method of preparing acellularized, biocompatible, implantable material
US8568761B2 (en) * 2005-07-15 2013-10-29 Cormatrix Cardiovascular, Inc. Compositions for regenerating defective or absent myocardium
US9072816B2 (en) * 2006-01-18 2015-07-07 Cormatrix Cardiovascular, Inc. Composition for modulating inflammation of cardiovascular tissue
KR101376013B1 (en) 2005-08-26 2014-03-19 리전츠 오브 더 유니버스티 오브 미네소타 Decellularization and recellularization of organs and tissues
WO2007056547A2 (en) * 2005-11-08 2007-05-18 Georgia Tech Research Corporation Acellularized biomaterial from embryonic stem cells
US20160082153A1 (en) * 2006-01-18 2016-03-24 Cormatrix Cardiovascular, Inc. Method and System for Treatment of Damaged Biological Tissue
GB0606231D0 (en) 2006-03-29 2006-05-10 Univ Leeds Improvements relating to decellurisation of tissue matrices for bladder implantation
NZ576372A (en) 2006-10-06 2012-02-24 Anthrogenesis Corp Native (telopeptide) placental collagen compositions
AU2013203210B2 (en) * 2006-10-06 2015-05-28 Celularity Inc. Native (telopeptide) placental collagen compositions
CN101616698A (en) 2006-10-23 2009-12-30 库克生物科技公司 The ECM material of the enhanced processing of component characteristic
CZ301086B6 (en) * 2007-10-17 2009-11-04 Bio-Skin, A. S. Sterile autogenous, allogenic or xenogenic implant and process for preparing thereof
EP2313120B1 (en) * 2008-08-14 2016-11-30 Kci Licensing, Inc. Tissue scaffolds
WO2012005760A1 (en) * 2010-06-30 2012-01-12 Miromatrix Medical Inc. Use of perfusion decellularized organs for matched recellularization
KR101900116B1 (en) 2010-09-01 2018-09-18 리전츠 오브 더 유니버스티 오브 미네소타 Methods of recellularizing a tissue or organ for improved transplantability
US20130013083A1 (en) * 2011-01-06 2013-01-10 Humacyte Tissue-Engineered Constructs
CA2822689C (en) 2011-01-06 2015-12-29 Humacyte Tissue-engineered constructs
AU2012262311B2 (en) 2011-05-31 2016-04-28 Lifecell Corporation Adipose tissue matrices
BR112014017140A8 (en) * 2012-01-16 2017-07-04 Koninklijke Philips Nv method of determining the presence of target molecules in a body fluid comprising cells; cartridge for insertion into an analyzer device; and analyzer device
WO2013134009A1 (en) 2012-03-08 2013-09-12 Lifecell Corporation Enzyme-activated collagen and tissue matrices
US9290738B2 (en) 2012-06-13 2016-03-22 Miromatrix Medical Inc. Methods of decellularizing bone
EP2869861B1 (en) 2012-07-05 2018-04-11 Lifecell Corporation Tissue-based drain manifolds
CN103536967B (en) * 2012-07-10 2016-04-13 上海微创医疗器械（集团）有限公司 A kind of method for removing cells preparing extracellular matrix support material
WO2014011402A1 (en) 2012-07-13 2014-01-16 Lifecell Corporation Methods for improved treatment of adipose tissue
AU2013323747B2 (en) 2012-09-26 2017-02-02 Lifecell Corporation Processed adipose tissue
US10035980B2 (en) 2013-01-14 2018-07-31 Florida State University Research Foundation, Inc. Extracellular matrix derived from stem cells and methods for production
CN105164250A (en) 2013-03-15 2015-12-16 米罗马特里克斯医疗公司 Use of perfusion decellularized liver for islet cell recellularization
CN104353115B (en) * 2014-10-29 2016-06-01 南通大学附属医院 Take off the test kit of cytoskeleton, the preparation of support for pancreas and plant method for planting again
CN105013014A (en) * 2015-07-31 2015-11-04 武汉蓝普医品有限公司 Preparation method and application of acellular matrix biological material
CN105920670A (en) * 2016-05-19 2016-09-07 李世荣 Degradable male genital organ patch composite material with biological elasticity and preparation method thereof
AU2017286715B2 (en) 2016-06-15 2022-03-03 The General Hospital Corporation Metabolic labeling and molecular enhancement of biological materials using bioorthogonal reactions
EP3481446B1 (en) 2016-07-05 2020-09-30 LifeCell Corporation Tissue matrices incorporating multiple tissue types
US11278643B2 (en) 2016-09-06 2022-03-22 Mayo Foundation For Medical Education And Research Use of resected liver serum for whole liver-engineering
EP3632481B1 (en) * 2017-05-30 2023-08-23 Adeka Corporation Method for producing decellularized material for transplantation and graft composition comprising biocompatible material including said material
CN107596446B (en) * 2017-09-16 2020-07-28 温州医科大学 Decellularization kit for maintaining tissue ultrastructure and nutrition microenvironment
US10821205B2 (en) 2017-10-18 2020-11-03 Lifecell Corporation Adipose tissue products and methods of production
US11123375B2 (en) 2017-10-18 2021-09-21 Lifecell Corporation Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
US11246994B2 (en) 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
EP3697462B1 (en) 2017-10-19 2023-07-12 LifeCell Corporation Flowable acellular tissue matrix products and methods of production
CN110876816A (en) * 2018-09-06 2020-03-13 韩嫣 Pig bladder source bioactive repair material
WO2020243497A1 (en) 2019-05-30 2020-12-03 Lifecell Corporation Biologic breast implant
CN111569151B (en) * 2020-05-12 2021-12-17 上海亚朋生物技术有限公司 Acellular dermal matrix tissue engineering scaffold and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8618374D0 (en) * 1986-07-28 1986-09-03 Hsc Res Dev Corp Biological vascular prostheses
US5735902A (en) * 1987-07-20 1998-04-07 Regen Biologics, Inc. Hand implant device
US5681353A (en) * 1987-07-20 1997-10-28 Regen Biologics, Inc. Meniscal augmentation device
JPH06505187A (en) * 1991-02-14 1994-06-16 バクスター　インターナショナル　インコーポレーテッド Flexible biograft material and method for manufacturing the same
ZA963151B (en) * 1995-04-19 1997-04-24 St Jude Medical Matrix substrate for a viable body tissue-derived prosthesis and method for making the same
US6376244B1 (en) * 1999-12-29 2002-04-23 Children's Medical Center Corporation Methods and compositions for organ decellularization

Also Published As

Publication number Publication date
WO2002040630A2 (en) 2002-05-23
AU2002224003A1 (en) 2002-05-27
WO2002040630A3 (en) 2004-06-10

Similar Documents

Publication Publication Date Title
IL139708A0 (en) Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering
AU8657601A (en) Composition and method for treatment of hypertriglyceridemia
HK1048949A1 (en) Method and composition for the treatment of scars
IL200540A (en) Tissue matrices comprising placental stem cells and methods of making them
EP1416044A4 (en) Support for cell / tissue culture and culture method
HK1047250A1 (en) Tissue augmentation material and methods
HK1030168A1 (en) Shaped bodies for use as implants in human medicine and method for the production of such shaped bodies
AU2001292917A1 (en) Method of preparing and processing transplant tissue
IL153687A0 (en) Composition and method for enhancing elasticity of tissue
GB2359021B (en) Method and composition for promoting hair growth
AU2001234831A1 (en) Magnetoliposome composition for targeted treatment of biological tissue and associated methods
GB2368397B (en) Method of treating biological specimens
AU5577101A (en) Enzymes useful for treating and methods for treating mps-vi and cells lines for producing such enzymes recombinantly
AU6137801A (en) Method and composition for the treatment of angiogenesis
GB2370115B (en) Method of treating biological specimens
GB2370635B (en) Method of treating biological specimens
AU5565401A (en) Materials and methods for the treatment of depression
AU2002337983A1 (en) Composition and method for treating erectile dysfunction and reducing fibrosis in erectile tissue of the human penis
DE29721310U1 (en) Spiral endoprosthesis that can be manufactured using the cutting process for implantation in hollow organs of the human body
IL137380A0 (en) Dental implant and method of implantation
EP1333862A4 (en) Methods of and pharmaceutical compositions for improving implantation of embryos
IL150202A0 (en) Method and composition for the treatment of pain
AU7452801A (en) Method of inducing gene expression in plant and the plant
GB0030295D0 (en) Porous sythetic bone graft and method of manufacture thereof
IL136600A0 (en) Structural beam and method of using